Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 13 de 13
Filtrer
1.
Skeletal Radiol ; 2023 Dec 29.
Article de Anglais | MEDLINE | ID: mdl-38157033

RÉSUMÉ

Understanding the traumatic mechanisms of ankle injuries in soccer is crucial for an accurate and complete MRI diagnosis. Many ankle injuries share universal mechanisms seen in other athletic activities, but certain patterns are found to be more specific and relatively unique to soccer. Ankle impingement syndromes encountered in soccer encompass a spectrum of disorders that include anterior and posterior impingement categories, with anterior impingement representing pathology relatively specific to soccer. Lateral ligamentous sprains are one of the most common injuries; however, there is a higher rate of injuries to the medial structures in soccer as compared to other sports. Ankle fractures are uncommon in soccer while bone contusions and chondral and osteochondral injuries frequently accompany ligamentous sprains. Tendon abnormalities in soccer most commonly result from overuse injuries and typically affect peroneal tendons, posterior and anterior tibialis tendons, and Achilles tendon. Acute Achilles tendon ruptures occur in both recreational players and elite soccer athletes. Tibialis anterior friction syndrome may mimic tibial stress fractures. Long-term sequelae of acute traumatic and chronic overuse ankle injuries in professional soccer players manifest as ankle osteoarthritis that is more prevalent compared to not only the general population, but also to former elite athletes from other sports. This article examines the most common and specific injuries in soccer in order of their frequency.

2.
J Clin Med ; 10(24)2021 Dec 13.
Article de Anglais | MEDLINE | ID: mdl-34945144

RÉSUMÉ

Posttraumatic osteoarthritis of the ankle and hindfoot is a common and frequently debilitating disorder. 70% to 90% of ankle osteoarthritis is related to prior trauma that encompasses a spectrum of disorders including fractures and ligamentous injuries that either disrupt the articular surface or result in instability of the joint. In addition to clinical evaluation, imaging plays a substantial role in the treatment planning of posttraumatic ankle and hindfoot osteoarthritis. Imaging evaluation must be tailored to specific clinical scenarios and includes weight bearing radiography that utilizes standard and specialty views, computed tomography which can be performed with a standard or a weight bearing technique, magnetic resonance imaging, and ultrasound evaluation. This review article aims to familiarize the reader with treatment rationale, to provide a brief review of surgical techniques and to illustrate expected imaging appearances of common operative procedures performed in the setting of posttraumatic ankle and hindfoot osteoarthritis, such as joint-preserving procedures, ankle fusion, subtalar fusion, tibiotalarcalcaneal fusion and ankle arthroplasty. Preoperative findings will be discussed along with the expected postoperative appearance of various procedures in order to improve detection of their complications on imaging and to provide optimal patient care.

5.
Radiographics ; 38(5): 1478-1495, 2018.
Article de Anglais | MEDLINE | ID: mdl-30118392

RÉSUMÉ

Several pathologic conditions may manifest as an osteochondral lesion of the knee that consists of a localized abnormality involving subchondral marrow, subchondral bone, and articular cartilage. Although understanding of these conditions has evolved substantially with the use of high-spatial-resolution MRI and histologic correlation, it is impeded by inconsistent terminology and ambiguous abbreviations. Common entities include acute traumatic osteochondral injuries, subchondral insufficiency fracture, so-called spontaneous osteonecrosis of the knee, avascular necrosis, osteochondritis dissecans, and localized osteochondral abnormalities in osteoarthritis. Patient demographics, the clinical presentation, and the role of trauma are critical for differential diagnosis. A localized osteochondral defect can be created acutely or can develop as an end result of several chronic conditions. MRI features that aid in diagnosis include the location and extent of bone marrow edema, the presence of a fracture line, a hypointense area immediately subjacent to the subchondral bone plate, and deformity of the subchondral bone plate. These findings are essential in diagnosis of acute traumatic injuries, subchondral insufficiency fracture, and its potentially irreversible form, spontaneous osteonecrosis of the knee. If the lesion consists of a subchondral region demarcated from the surrounding bone, the demarcation should be examined for completeness and the presence of a "double-line sign" that is seen in avascular necrosis or findings of instability, which are important for proper evaluation of osteochondritis dissecans. Subchondral bone plate collapse, demonstrated by the presence of a depression or a fluid-filled cleft, can be seen in advanced stages of both avascular necrosis and subchondral insufficiency fracture, indicating irreversibility. Once the diagnosis is established, it is important to report pertinent MRI findings that may guide treatment of each condition. ©RSNA, 2018 An earlier incorrect version of this article appeared online. This article was corrected on August 23, 2018.


Sujet(s)
Fractures du fémur/imagerie diagnostique , Traumatismes du genou/imagerie diagnostique , Articulation du genou/imagerie diagnostique , Imagerie par résonance magnétique/méthodes , Gonarthrose/imagerie diagnostique , Ostéochondrite disséquante/imagerie diagnostique , Ostéonécrose/imagerie diagnostique , Maladies de la moelle osseuse/imagerie diagnostique , Maladies de la moelle osseuse/anatomopathologie , Maladies du cartilage/imagerie diagnostique , Maladies du cartilage/anatomopathologie , Diagnostic différentiel , Fractures du fémur/anatomopathologie , Humains , Traumatismes du genou/anatomopathologie , Articulation du genou/anatomopathologie , Gonarthrose/anatomopathologie , Ostéochondrite disséquante/anatomopathologie , Ostéonécrose/anatomopathologie
6.
AJR Am J Roentgenol ; 210(6): 1235-1239, 2018 Jun.
Article de Anglais | MEDLINE | ID: mdl-29667884

RÉSUMÉ

OBJECTIVE: The purpose of this study was to retrospectively determine whether the egg-and-banana sign, defined as the visualization of the main pulmonary artery (PA) at the level of the aortic arch, is a sensitive and specific diagnostic marker for pulmonary hypertension. MATERIALS AND METHODS: A total of 186 patients who, between January 2014 and July 2017, received right heart catheterizations and underwent CT studies that included the aortic arch within 140 days of catheterization were evaluated in this retrospective study. Of these patients, 127 had pulmonary hypertension (PH), and 59 who did not have PH served as control subjects. Two blinded radiologists reviewed each study for the egg-and-banana sign. The diameters of the main PA and ascending aorta were also measured. Contingency tables, ROC curves, and a t test were used for statistical analysis. RESULTS: The egg-and-banana sign was associated with a higher mean PA pressure, a higher ratio of the diameter of the PA to the diameter of the ascending aorta (Ao) (hereafter referred to as the "PA-to-Ao ratio"), and a larger PA diameter (p < 0.006). It had a specificity of 85% and a positive predictive value of 85%. When the egg-and-banana sign was used in combination with a main PA diameter larger than 29 mm and a PA-to-Ao ratio greater than 1, its specificity increased to 91% and 93%, respectively. When considered as individual markers, the PA diameter had a high sensitivity (80%; AUC value, 0.74) and the PA-to-Ao ratio had a high specificity (81%; AUC value, 0.73) for PH. Moderate correlations were noted between PA pressure and PA diameter (r = 0.37) and between PA pressure and PA-to-Ao ratio (r = 0.43). CONCLUSION: The egg-and-banana sign has a high specificity and PPV for PH. Specificity increased when the sign was used in combination with other classic CT markers.


Sujet(s)
Hypertension pulmonaire/imagerie diagnostique , Artère pulmonaire/imagerie diagnostique , Tomodensitométrie/méthodes , Sujet âgé , Aorte/imagerie diagnostique , Cathétérisme cardiaque , Techniques d'imagerie cardiaque synchronisée , Études cas-témoins , Produits de contraste , Diagnostic différentiel , Femelle , Humains , Iopamidol , Mâle , Adulte d'âge moyen , Tomographie par émission de positons couplée à la tomodensitométrie , Valeur prédictive des tests , Études rétrospectives , Sensibilité et spécificité
7.
J Am Coll Radiol ; 14(11S): S421-S448, 2017 Nov.
Article de Anglais | MEDLINE | ID: mdl-29101982

RÉSUMÉ

Total knee arthroplasty (TKA) is the most commonly performed joint replacement procedure in the United States and annual demand for primary TKA is expected to grow by 673% by 2030. The first part provides an overview of imaging modalities (radiographs, CT, MRI, ultrasound, and various nuclear medicine studies) and discusses their usefulness in the imaging evaluation of TKA. The second part focuses on evidence-based imaging and imaging-guided intervention algorithms for the workup of TKA and its complications, including routine follow-up, component wear, periprosthetic infection, aseptic loosening, granulomas/osteolysis, conventional and rotational instability, periprosthetic fracture, patellar complications, and a variety of periprosthetic soft tissue abnormalities. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.


Sujet(s)
Arthroplastie prothétique de genou , Imagerie diagnostique/méthodes , Complications postopératoires/imagerie diagnostique , Médecine factuelle , Humains , Sociétés médicales , États-Unis
8.
J Foot Ankle Surg ; 56(6): 1335-1338, 2017.
Article de Anglais | MEDLINE | ID: mdl-28818476

RÉSUMÉ

Musculoskeletal anatomy is widely known to have components that stray from the norm in the form of variant muscle and tendon presence, absence, origin, insertion, and bifurcation. Although these variant muscles and tendons might be deemed incidental and insignificant findings by most, they can be important contributors to pathologic physiology or, more importantly, an option for effective treatment. In the present case report, we describe a patient with phocomelia and Müllerian abnormalities secondary to in utero thalidomide exposure. The patient had experienced recurrent bilateral foot pain accompanied by numbness, stiffness, swelling, and longstanding pes planus. These symptoms persisted despite conservative treatment with orthotics, steroids, and nonsteroidal anti-inflammatory drugs. Radiographic imaging showed dysmorphic and degenerative changes of the ankle and foot joints. Further investigation with magnetic resonance imaging revealed complex anatomic abnormalities, including the absence of the posterior tibialis and peroneus brevis, lateralization of the peroneus longus, and the presence of a variant anterior compartment muscle. The variant structure was likely a previously described anterior compartment variant, anterior fibulocalcaneus, and might have been a source of the recurrent pain. Also, the absence of the posterior tibialis might have caused the pes planus in the present patient, considering that posterior tibialis tendon dysfunction is the most common cause of acquired pes planus. Although thalidomide infrequently affects the lower extremities, its effects on growth and development were likely the cause of this rare array of anatomic abnormalities and resulting ankle and foot pathologic features.


Sujet(s)
Malformations dues aux médicaments et aux drogues/imagerie diagnostique , Ectromélie/diagnostic , Muscles squelettiques/malformations , Tendons/malformations , Thalidomide/effets indésirables , Malformations dues aux médicaments et aux drogues/physiopathologie , Articulation talocrurale/malformations , Articulation talocrurale/imagerie diagnostique , Ectromélie/complications , Femelle , Études de suivi , Articulations du pied/malformations , Articulations du pied/imagerie diagnostique , Humains , Membre inférieur/physiopathologie , Imagerie par résonance magnétique/méthodes , Adulte d'âge moyen , Muscles squelettiques/anatomie et histologie , Maladies rares , Appréciation des risques , Indice de gravité de la maladie , Tendons/anatomie et histologie , Thalidomide/administration et posologie
9.
Radiographics ; 35(3): 765-79, 2015.
Article de Anglais | MEDLINE | ID: mdl-25969933

RÉSUMÉ

The talus, the second largest tarsal bone, has distinctive imaging characteristics and injury patterns. The predominantly extraosseous vascular supply of the talus predisposes it to significant injury in the setting of trauma. In addition, the lack of muscular attachments and absence of a secondary blood supply can lead to subsequent osteonecrosis. Although talar fractures account for less than 1% of all fractures, they commonly result from high-energy trauma and may lead to complications and long-term morbidity if not recognized and managed appropriately. While initial evaluation is with foot and ankle radiographs, computed tomography (CT) is often performed to evaluate the extent of the fracture, displacement, comminution, intra-articular extension, and associated injuries. Talar fractures are divided by anatomic region: head, neck, and body. Talar head fractures can be treated conservatively if nondisplaced, warranting careful radiographic and CT evaluation to assess rotation, displacement, and extension into the neck. The modified Hawkins-Canale classification of talar neck fractures is most commonly used due to its simplicity, usefulness in guiding treatment, and prognostic value, as it correlates associated malalignment with risk of subsequent osteonecrosis. Isolated talar body fractures may be more common than previously thought. The Sneppen classification further divides talar body fractures into osteochondral talar dome, lateral and posterior process, and shear and crush comminuted central body fractures. Crush comminuted central body fractures carry a poor prognosis due to nonanatomic reduction, bone loss, and subsequent osteonecrosis. Lateral process fractures can be radiographically occult and require a higher index of suspicion for successful diagnosis. Subtalar dislocations are often accompanied by fractures, necessitating postreduction CT. Familiarity with the unique talar anatomy and injury patterns is essential for radiologists to facilitate appropriate and timely management.


Sujet(s)
Fractures osseuses/classification , Fractures osseuses/imagerie diagnostique , Luxations/classification , Luxations/imagerie diagnostique , Talus/traumatismes , Tomodensitométrie , Produits de contraste , Humains
10.
AJR Am J Roentgenol ; 200(4): 856-9, 2013 Apr.
Article de Anglais | MEDLINE | ID: mdl-23521460

RÉSUMÉ

OBJECTIVE: The purpose of this study was to determine the rate of discrepancy between radiology residents and attending musculoskeletal radiologists in interpretation of on-call musculoskeletal radiographs. MATERIALS AND METHODS: We performed a retrospective review of 2219 consecutive musculoskeletal radiology reports on patients who visited the emergency department between January 2009 and December 2010. The images were initially interpreted overnight by on-call residents (postgraduate years 3-5), and a final interpretation was rendered the next morning by a musculoskeletal radiologist. The reports were evaluated for major discrepancies, such as missed fractures, osteomyelitis, foreign bodies, tumors, and acute arthritic conditions, which were defined as cases in which a change in clinical management was needed and required notification of the emergency care provider. RESULTS: The overall discrepancy rate was 1.8% (40/2219). Fractures accounted for 62.5% (25/40) of missed findings. Fractures involving the upper extremity, particularly the hand and wrist (2.2% [9/405]), were the most frequently missed. Radial fractures accounted for 50% (7/14) of the missed upper extremity fractures. Foreign bodies (10% [4/40]) and tumorlike lesions (7.5% [3/40]) accounted for the next most common misses. Finally, independent resident readings in the on-call setting had little adverse effect on patient care. CONCLUSION: In the on-call setting, the low discrepancy rate between interpretations of musculoskeletal radiographs by residents and by musculoskeletal attending radiologists is comparable to that reported for other body parts and modalities. Residents should be aware of the relatively high rate of missed pathologic findings in the upper extremity, especially the radius.


Sujet(s)
Compétence clinique , Erreurs de diagnostic/statistiques et données numériques , Internat et résidence , Maladies ostéomusculaires/diagnostic , Radiologie/normes , Adulte , Loi du khi-deux , Femelle , Humains , Mâle , Radiologie/enseignement et éducation , Études rétrospectives
11.
J Nucl Med ; 53(4): 567-74, 2012 Apr.
Article de Anglais | MEDLINE | ID: mdl-22381410

RÉSUMÉ

UNLABELLED: We investigated the correlation between metabolic response by (18)F-FDG PET and objective response, glucose transporter type 4 (GLUT4) expression, and KIT/PDGFRA mutation status in patients with gastrointestinal stromal tumor undergoing neoadjuvant imatinib mesylate therapy. METHODS: (18)F-FDG PET was performed at baseline, 1-7 d, and 4 or 8 wk after imatinib mesylate initiation. Best objective response was defined by version 1.0 of the Response Evaluation Criteria in Solid Tumors (RECIST). Mutational analysis and tumor GLUT4 expression by immunohistochemistry were done on tissue obtained at baseline or surgery. RESULTS: (18)F-FDG PET showed high baseline tumor glycolytic activity (mean SUV(max), 14.2; range, 1.3-53.2), decreasing after 1 wk of imatinib mesylate (mean, 5.5; range, -0.5-47.7, P < 0.001, n = 44), and again before surgery (mean, 3.0; range, -0.5-36.1, P < 0.001, n = 40). At week 1, there were 3 patients with complete metabolic response (CMR), 33 with partial metabolic response (PMR), 6 with stable metabolic disease (SMD), and 2 with progressive metabolic disease (PMD). Before surgery, there were 3 with CMR, 33 with PMR, 4 with SMD, and none with PMD. The best response according to RECIST was 2 with partial response, 36 with stable disease, and 1 with progressive disease (n = 39). Of the patients with a posttreatment decrease in GLUT4 expression, 1 had CMR, 15 had PMR, 2 had SMD, and 1 had PMD at week 1, whereas before surgery 1 patient had CMR, 16 had PMR, 2 had SMD, and none had PMD. Among 27 patients with KIT exon 11 mutations, 1 had CMR, 22 had PMR, 3 had SMD, and 1 had PMD at week 1, whereas 1 had CMR, 22 had PMR, 2 had SMD, and 2 were unknown before surgery; among 4 patients with a wild-type genotype, 2 had PMR and 2 SMD at week 1, whereas 1 had CMR, 2 had PMR, and 1 had SMD before surgery. CONCLUSION: After imatinib mesylate initiation, metabolic response by (18)F-FDG PET was documented earlier (1-7 d) and was of much greater magnitude (36/44) than that documented by RECIST (2/39). Immunohistochemistry data suggest that GLUT4 may play a role in (18)F-FDG uptake in gastrointestinal stromal tumor, GLUT4 levels decrease after imatinib mesylate therapy in most patients with PMR, and the biologic action of imatinib mesylate interacts with glycolysis and GLUT4 expression. A greater than 85% metabolic response was observed as early as days 1-7 in patients with exon 11 mutations.


Sujet(s)
Fluorodésoxyglucose F18 , Tumeurs gastro-intestinales/traitement médicamenteux , Tumeurs stromales gastro-intestinales/traitement médicamenteux , Génotype , Traitement néoadjuvant/méthodes , Pipérazines/usage thérapeutique , Tomographie par émission de positons , Pyrimidines/usage thérapeutique , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Benzamides , Transport biologique , Femelle , Fluorodésoxyglucose F18/métabolisme , Tumeurs gastro-intestinales/imagerie diagnostique , Tumeurs gastro-intestinales/génétique , Tumeurs gastro-intestinales/chirurgie , Tumeurs stromales gastro-intestinales/imagerie diagnostique , Tumeurs stromales gastro-intestinales/génétique , Tumeurs stromales gastro-intestinales/chirurgie , Régulation de l'expression des gènes tumoraux , Transporteur de glucose de type 4/génétique , Humains , Traitement d'image par ordinateur , Mésilate d'imatinib , Mâle , Adulte d'âge moyen , Mutation , Traitement néoadjuvant/effets indésirables , Pipérazines/effets indésirables , Protéines proto-oncogènes c-kit/génétique , Pyrimidines/effets indésirables , Facteurs temps , Résultat thérapeutique , Jeune adulte
12.
Skeletal Radiol ; 40(7): 831-42, 2011 Jul.
Article de Anglais | MEDLINE | ID: mdl-20526774

RÉSUMÉ

Fractures of the clavicle account for 2.6-5% of all fractures. Clavicular fractures have traditionally been treated conservatively, however, there has recently been increased interest in surgical repair of displaced clavicular fractures, with resultant lower rates of nonunion and malunion. Treatment of acromioclavicular (AC) separation has traditionally been conservative, with surgery reserved for patients with chronic pain or significant dislocation and acute soft tissue injury. It is important for the radiologist to become familiar with the surgical techniques used to fixate these fractures as well as the post-operative appearance and potential complications.


Sujet(s)
Articulation acromioclaviculaire/imagerie diagnostique , Articulation acromioclaviculaire/traumatismes , Clavicule/imagerie diagnostique , Clavicule/traumatismes , Fractures osseuses/diagnostic , Fractures osseuses/chirurgie , Articulation acromioclaviculaire/chirurgie , Clavicule/chirurgie , Humains , Imagerie par résonance magnétique/méthodes , Tomodensitométrie/méthodes
13.
Clin Cancer Res ; 13(20): 6175-81, 2007 Oct 15.
Article de Anglais | MEDLINE | ID: mdl-17947484

RÉSUMÉ

PURPOSE: Pertuzumab, a first-in-class human epidermal receptor 2 (HER2) dimerization inhibitor, is a humanized monoclonal anti-HER2 antibody that binds HER2's dimerization domain and inhibits HER2 signaling. Based on supporting preclinical studies, we undertook a Phase II trial of pertuzumab in patients with recurrent non-small cell lung cancer (NSCLC). EXPERIMENTAL DESIGN: Patients with previously treated NSCLC accessible for core biopsy and naive to HER pathway inhibitors were treated with pertuzumab i.v. once every 3 weeks. Tumor assessments were done at 6 and 12 weeks and then every 3 months thereafter. The primary efficacy end point was overall response rate by Response Evaluation Criteria in Solid Tumors. Measurement of tumor glucose metabolism (SUVmax) by F-18-fluorodeoxyglucose positron emission tomography was used as an exploratory pharmacodynamic marker of drug activity. RESULTS: Of 43 patients treated with pertuzumab, no responses were seen; 18 of 43 (41.9%) and 9 of 43 (20.9%) patients had stable disease at 6 and 12 weeks, respectively. The median and 3-month progression-free survival rates (PFS) were 6.1 weeks (95% confidence interval, 5.3-11.3 weeks) and 28.4% (95% confidence interval, 14.4-44.2%), respectively. Of 22 patients who underwent F-18-fluorodeoxyglucose positron emission tomography, six (27.3%) had a metabolic response to pertuzumab as evidenced by decreased SUV max. These patients had prolonged PFS (HR = 0.11, log-rank P value = 0.018) compared with the 16 patients who had no metabolic response. Four patients (9.3%) experienced a grade 3/grade 4 adverse event judged related to pertuzumab; none exhibited grade 3/grade 4 cardiac toxicity. CONCLUSIONS: Pertuzumab is well tolerated as monotherapy. Pharmacodynamic activity correlated with prolonged PFS was detected in a moderate percentage of patients (27.3%). Further clinical development of pertuzumab should focus on rational combinations of pertuzumab with other drugs active in NSCLC.


Sujet(s)
Anticorps monoclonaux/usage thérapeutique , Antinéoplasiques/usage thérapeutique , Carcinome pulmonaire non à petites cellules/traitement médicamenteux , Tumeurs du poumon/traitement médicamenteux , Récepteur ErbB-2/composition chimique , Adulte , Anticorps monoclonaux humanisés , Biopsie , Dimérisation , Récepteurs ErbB/métabolisme , Femelle , Fluorodésoxyglucose F18/pharmacologie , Humains , Mâle , Adulte d'âge moyen , Mutation , Tomographie par émission de positons/méthodes , Structure tertiaire des protéines , Récepteur ErbB-2/antagonistes et inhibiteurs , Facteurs temps , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE